Next Article in Journal
Leveraging Natural Compounds for Pancreatic Lipase Inhibition via Virtual Screening
Next Article in Special Issue
Leveraging Acquired EGFR-TKI-Resistant Models to Identify MUC16 as a Therapeutic Vulnerability in Lung Adenocarcinoma
Previous Article in Journal
Advances in the Application of Graphene and Its Derivatives in Drug Delivery Systems
Previous Article in Special Issue
Tumor Microenvironmental Dynamics in Shaping Resistance to Therapeutic Interventions in Melanoma: A Narrative Review
 
 
Review

Article Versions Notes

Pharmaceuticals 2025, 18(9), 1244; https://doi.org/10.3390/ph18091244
Action Date Notes Link
article html file updated 1 September 2026 11:07 CEST Update https://www.mdpi.com/1424-8247/18/9/1244/html
article html file updated 22 August 2025 15:17 CEST Original file -
article pdf uploaded. 22 August 2025 15:14 CEST Version of Record https://www.mdpi.com/1424-8247/18/9/1244/pdf
article xml uploaded. 22 August 2025 15:14 CEST Update https://www.mdpi.com/1424-8247/18/9/1244/xml
article xml file uploaded 22 August 2025 15:14 CEST Original file -
Back to TopTop